Chemo for glioblastoma may work better in morning than evening

(Washington University School of Medicine) An aggressive type of brain cancer, glioblastoma has no cure. Patients survive an average of 15 months after diagnosis, with fewer than 10% of patients surviving longer than five years. While researchers are investigating potential new therapies via ongoing clinical trials, a new study from Washington University in St. Louis suggests that a minor adjustment to the current standard treatment -- giving chemotherapy in the morning rather than the evening -- could add a few months to patients' survival.
Source: EurekAlert! - Medicine and Health - Category: International Medicine & Public Health Source Type: news